companies making glp-1 drugs Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 The Rise of GLP-1 Medications

Glycemia reduction in type 2 diabetes microvascular and cardiovascular outcomes

129 TakeoS.AraiH.KusanoN.HaradaT.FuruyaT.KawauchiS.et al (2001)

The article on how long peptides last at room temperature quantifies this degradation rate, and the answer is sobering for anyone who has been careless with storage

A recent meta-analysis showed that SGLT2i and, to a lesser extent, DPP4i are associated with greater glucose-lowering efficacy in patients from Asian ethnicity [35]

Some foreign scholars compared the number of pancreatic cancer patients treated with exenatide and those treated with other hypoglycemic drugs, and the results revealed that the number of pancreatic cancer patients treated with exenatide was 2.9 times greater than that of patients treated with other hypoglycemic drugs (82)